Ally Bridge Group NY LLC Decreases Stake in Tarsus Pharmaceuticals, Inc. $TARS

Chronological Source Flow
Back

AI Fusion Summary

Ally Bridge Group NY LLC cut its Tarsus Pharmaceuticals stake by 41.6% in Q3, selling 50,404 shares and leaving 70,778 shares, reducing the holding to 2.6% of its portfolio ($4.21 M). Other funds also adjusted positions.
15/03 09:31 defenseworld.net
3 Πηγές
15/03 10:02 defenseworld.net
15/03 11:34 defenseworld.net
Comments
Loading...
0